Optos
MARLBOROUGH, MA, March 20, 2008 – Optos, a leading medical technology company for the design, development, manufacturing and marketing of retinal imaging devices, today announced the full commercial release and installation of its newest device – P200MA – at the prestigious Weill Cornell Medical College, Department of Ophthalmology, New York, NY.
"The P200MA is an amazing device that delivers substantial advancement in retinal disease detection and evaluation for today’s ophthalmologist,” stated Donald D’Amico, MD, Professor and Chairman of Ophthalmology at Weill Cornell Medical College and Ophthalmologist-in-Chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. “The optomap® fa color images produce the most eloquent, dramatic, and compelling view of the fundus, which will greatly enhance patient care and education. The device also provides superb image documentation that will be utilized for almost every patient visit.”
Optos’ P200MA device is a new imaging platform that produces the optomap® fa Angiography Procedure. Patients are injected with sodium fluorescein which rapidly works its way through the patient’s blood vessels and enables the doctor to dynamically and rapidly capture ultra-widefield images of the fluoresced blood vessels of the patient’s retina in real time. The device offers advanced image capture and review capabilities in disease diagnosis and treatment monitoring. The optomap® fa Angiography Procedure provides practitioners with access to reimbursement.
“Clinically we expect our new device to be very useful in the diagnosis and management of a number of pole to peripheral pathologies, and particularly diabetes by enabling doctors to carry out highly targeted partial pan-retinal photocoagulation - this will allow for new treatment paradigms and improved patient outcomes,” said Thomas W. Butts, Chief Executive Officer. “We are very pleased to deliver this device to retinal specialists as it opens new global market segments for us within the medical care segment, of which we estimate a target opportunity of approximately 2.7 million procedures annually in our existing markets in North America and Europe.”
Dr. D’Amico and his colleagues at Weill Cornell Eye Associates, a practice group of the Weill Medical College, Department of Ophthalmology, at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, are using the P200MA to diagnose and treat patients with a myriad of retinal disorders. Weill Cornell Eye Associates is a state-of-the-art facility equipped with advanced diagnostic technologies like the P200MA to help provide high quality patient care. The center offers a full range of ophthalmic services including cataract, cornea and external disease, retinal and vitreous disorders, glaucoma, pediatric ophthalmology, oculoplastics, and neuro-ophthalmology.
Note to Editors
Optos plc is a leading and rapidly growing medical technology company for the design, development, manufacturing and marketing of devices that image the retina, the light-sensitive area at the back of the eye. Optos' platform technology is the Panoramic200 Scanning Laser Ophthalmoscope device - known as the P200. In a quarter of a second the P200 device produces a high resolution image of up to 200 degrees or approximately 82 percent of the retina in a single capture. The image - branded the optomap® Retinal Exam - provides eye care practitioners with clinically useful information that facilitates the early detection of disorders and diseases evidenced in the retina, such as glaucoma, diabetic retinopathy and age-related macular degeneration. Retinal imaging can also indicate evidence of non-eye or systemic diseases such as diabetes, hypertension and certain cancers. Optos’ technology provides an unequalled combination of wide-field retinal imaging, speed and convenience for both practitioner and patient and can help save sight and save lives.
________________________________________
Karen Whelan | Senior Public Relations & Practice Marketing Specialist
67 Forest Street
Marlborough, MA 01752
Direct: 508-787-1461
Toll Free: 877-455-8855 x1461
Cust. Support: 800-854-3039
Facsimile: 508-787-1445
Email: [email protected]
Web: optos.com